Pharmacokinetics and drug metabolism in the elderly

References

• Advenier C, Saint-Aubin A, Gobert C, Houin G, Albengres E, Tillement JP. (1980). Pharmacokinetics of isoniazid in the elderly. Br J Clin Pharmacol 10:167–169.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Mandel R, Fain MJ. (2007). Frailty: an emerging geriatric syndrome. Am J Med 120:748–753.
   PubMed Web of Science ®Google Scholar
• Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, Schüttler J. (1999) The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther 65:630–639.
   PubMed Web of Science ®Google Scholar
• Anantharaju A, Feller A, Chedid A. (2002). Aging liver. A review. Gerontology 48:343–353.
   PubMed Web of Science ®Google Scholar
• Benedetti MS, Whomsley R, Canning M. (2007). Drug metabolism in the paediatric population and in the elderly. Drug Discov Today 12:599–610.
   PubMed Web of Science ®Google Scholar
• Benet LZ, Hoener BA. (2002). Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71:115–121.
   PubMed Web of Science ®Google Scholar
• Bigos KL, Pollock BG, Coley KC, del Miller D, Marder SR, Aravagiri M, Kirshner MA, Schneider LS, Bies RR. (2008). Sex, race, and smoking impact olanzepine exposure. J Clin Pharmacol 48:157–165.
   PubMed Web of Science ®Google Scholar
• Borst P, Elfering RO. (2002). Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592.
   PubMed Web of Science ®Google Scholar
• Brenner SS, Klotz U. (2004). P-glycoprotein function in the elderly. Eur J Clin Pharmacol 60:97–102.
   PubMed Web of Science ®Google Scholar
• Brenner SS, Herrlinger C, Dilger K, Mürdter TE, Hofmann U, Marx C, Klotz U. (2003). Influence of age and cytochrome P4502C9 genotype on the steady-state disposition of diclofenac and celecoxib. Clin Pharmacokinet 42:283–292.
   PubMed Web of Science ®Google Scholar
• Butler JM, Begg EJ. (2008). Free drug metabolic clearance in elderly people. Clin Pharmacokinet 47:297–321.
   PubMed Web of Science ®Google Scholar
• Chapron DJ, Cameron IR, White LB, Merrall P. (1982). Observations on lithium disposition in the elderly. J Am Geriatr Soc 30:651–655.
   PubMed Web of Science ®Google Scholar
• Cresswell KM, Fernando BF, McKinstry B, Sheikh A. (2007). Adverse drug events in the elderly. Br Med Bull 83:259–274.
   PubMed Web of Science ®Google Scholar
• Dilger K, Hofmann U, Klotz U. (2000). Enzyme induction in the elderly: effect of rifampicin on pharmacokinetics and pharmacodynamics of propafenone. Clin Pharmacol Ther 67:512–520.
   PubMed Web of Science ®Google Scholar
• Dobson PD, Kell DB. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev/Drug Discov 7:205–215.
   PubMed Web of Science ®Google Scholar
• Doucet J, Queneau P. (2005). Adverse drug reactions in the elderly. Bull Acad Natl Med 189:1693–1707; discussion, 1708–1709.
   PubMed Web of Science ®Google Scholar
• Edholm M, Gil Berglund E, Salmonson T. (2008). Regulatory aspects of pharmacokinetic profiling in special populations: a European perspective. Clin Pharmacokinet 47:693–701.
   PubMed Web of Science ®Google Scholar
• Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M. (1996). Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydromethylantipyrine, and norantipyrine formation. Clin Pharmacol Ther 59:613–623.
   PubMed Web of Science ®Google Scholar
• Faber MS, Fuhr U. (2004). Time response of cytochrome P4501A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 76:178–184.
   PubMed Web of Science ®Google Scholar
• Feng Y, Pollock BG, Ferrell RE, Kimak MA, Reynolds, CFIII, Bies, RR. (2006). Paroxetine: population pharmacokinetics analysis in late-life depression using sparse concentration sampling. Br J Clin Pharmacol 61:558–569.
   PubMed Web of Science ®Google Scholar
• Fliser D, Bischoff I, Hanses A, Block S, Joest M, Ritz E, Mutschler E. (1999). Renal handling of drugs in the healthy elderly. Eur J Clin Pharmacol 55:205–211.
   PubMed Web of Science ®Google Scholar
• Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. (1997). Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 51:1196–1204.
   PubMed Web of Science ®Google Scholar
• Fliser D, Franek E, Ritz E. (1997). Renal function in the elderly—is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transpl 12:1553–1555.
   PubMed Web of Science ®Google Scholar
• Frassetto LA, Poon S, Tsourounis C, Valera C, Benet LZ. (2007). Effects of uptake and efflux transporter inhibition on erythromycin breath test results. Clin Pharmacol Ther 81:828–832.
   PubMed Web of Science ®Google Scholar
• Froissart M, Rossert J. (2005). How to improve estimation of renal function in the elderly. Rev Prat 55:2223–2229.
   PubMedGoogle Scholar
• Fromm MF, Dilger K, Busse D, Kroemer HK, Eichelbaum M, Klotz U. (1998). Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction. Br J Clin Pharmacol 45:247–255.
   PubMed Web of Science ®Google Scholar
• Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B, Hall SD. (2003). The effect of age, sex, and rifampicin administration on intestinal and hepatic cytochrome P4503A activity. Clin Pharmacol Ther 74:275–287.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. (1984). Effect of age, gender, and obesity on midazolam kinetics. Anaesthesiology 61:27–35.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI. (1982). Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. J Pharmacol Exp Ther 220:120–126.
   PubMed Web of Science ®Google Scholar
• Greenblatt DY, Shader RI, Harmatz JS. (1989). Implications of altered drug disposition in the eldery: studies with benzodiazepines. J Clin Pharmacol 29:866–872.
   PubMed Web of Science ®Google Scholar
• Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman UA. (2005). A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Cand J Clin Lab Invest 65:153–162.
   PubMed Web of Science ®Google Scholar
• Hämmerlein A, Derendorf H, Lowenthal DT. (1998). Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet 35:49–64.
   PubMed Web of Science ®Google Scholar
• Hanratty CG, McGlinchey P, Johnston GD, Passmore AP. (2000). Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging 17:353–362.
   PubMed Web of Science ®Google Scholar
• Hardy BG, Shulman KI, Mackenzie SE, Kutcher SP, Silverberg JD. (1987). Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol 7:153–158.
   PubMed Web of Science ®Google Scholar
• Harper KW, Collier PS, Dundee JW, Elliott P, Halliday NJ, Lowry KG. (1985). Age and nature of operation influence the pharmacokinetics of midazolam. Br J Anaesth 57:866–871.
   PubMed Web of Science ®Google Scholar
• Herrlinger C, Klotz U. (2001). Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol 15:897–918.
   PubMed Web of Science ®Google Scholar
• Hilmer SN, McLachlan AJ, Le Couteur DG. (2007). Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 21:217–230.
   PubMed Web of Science ®Google Scholar
• Hubbard RE, O’Mahony MS, Calver BL, Woodhouse KW. (2008). Plasma esterases and inflammation in ageing and frailty. Eur J Clin Pharmacol 64:895–900.
   PubMed Web of Science ®Google Scholar
• Hunt CM, Westerkam WR, Stave GM. (1992). Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 44:275–283.
   PubMed Web of Science ®Google Scholar
• Hutchison LC, O’Brien CE. (2007). Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Pract 20:4–12.
   Google Scholar
• Ishizawa Y, Yasui-Furukori N, Takahata T, Sasaki M, Tateishi T. (2005). The effect of aging on the relationship between the cytochrome P4502C19 genotype and omeprazole pharmacokinetics. Clin Pharmacokinet 44:1179–1189.
   PubMed Web of Science ®Google Scholar
• James OF. (1997). Parenchymal liver disease in the elderly. Gut 41:430–432.
   PubMed Web of Science ®Google Scholar
• Kennerfalk A, Ruigómez A, Wallander MA, Wilhelmsen L, Johansson S. (2002). Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36:797–803.
   PubMed Web of Science ®Google Scholar
• Kinirons MT, O’Mahony MS. (2004). Drug metabolism and ageing. Br J Clin Pharmacol 57:540–544.
   PubMed Web of Science ®Google Scholar
• Klotz U. (1998). Effect of age on pharmacokinetics and pharmacodynamics in man. Intern J Clin Pharmacol Ther 36:581–585.
   PubMed Web of Science ®Google Scholar
• Klotz U. (2003). Effect of aging on the pharmacokinetics of gastrointestinal drugs. In: Pilotti A, Malferthheiner P, Holt PR( eds.), Aging and the Gastrointestinal Tract. Interdisciplinary Topics in Gerontology, Vol. 32 ( pp 28–39). Basel, Switzerland: Karger.
   Google Scholar
• Klotz U. (2007). The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 46:271–279.
   PubMed Web of Science ®Google Scholar
• Klotz U. (2008). The elderly—a challenge for appropriate drug treatment. Eur J Clin Pharmacol 64:225–226.
   PubMed Web of Science ®Google Scholar
• Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR. (1975). The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55:347–359.
   PubMed Web of Science ®Google Scholar
• Klotz U, Fischer C, Müller-Seydlitz P, Schulz J, Müller WA. (1979). Alterations in the disposition of differently cleared drugs in patients with cirrhosis. Clin Pharmacol Ther 26:221–227.
   PubMed Web of Science ®Google Scholar
• Klotz U, Schwab M, Treiber G. (2004). CYP2C19 polymorphism and proton pump inhibitors. Basic Clin Pharmacol Toxicol 95:2–8.
   PubMed Web of Science ®Google Scholar
• Kurnik D, Wood AJ, Wilkinson GR. (2006). The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity. Clin Pharmacol Ther 80:228–234.
   PubMed Web of Science ®Google Scholar
• Laroche ML, Charmes JP, Marcheix A, Bouthier F, Merle L. (2006). Estimation of glomerular filtration rate in the elderly: Cockcraft-Gault formula versus modification of diet in renal disease formula. Pharmacotherapy 26:1041–1046.
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. (2005). The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 44:187–200.
   PubMed Web of Science ®Google Scholar
• Le Couteur DG, McLean AM. (1998). The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 34:359–373.
   PubMed Web of Science ®Google Scholar
• Lin JH, Yamazaki M. (2003). Role of P-glycoprotein in pharmacokinetics. Clinical implications. Clin Pharmacokinet 42:59–98.
   PubMed Web of Science ®Google Scholar
• Lindeman RD, Tobin J, Shock NW. (1985). Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278–285.
   PubMed Web of Science ®Google Scholar
• Link B, Haschke M, Grignaschi N, Bodmer M, Aschmann YZ, Wenk M, Krähenbühl S. (2008). Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping. Br J Clin Pharmacol 66:473–484.
   PubMed Web of Science ®Google Scholar
• Machado CG, Calado RT, Garcia AB, Falcao RP. (2003). Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T-lymphocytes. Braz J Med Biol Res 36:1653–1657.
   PubMed Web of Science ®Google Scholar
• Mallet L, Spinewine A, Huang A. (2007). Prescribing in elderly people. 2. The challenge of managing drug interactions in elderly people. Lancet 370:185–191.
   PubMed Web of Science ®Google Scholar
• McLean AJ, Le Couteur DG. (2004). Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163–184.
   PubMed Web of Science ®Google Scholar
• Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G, Sposato I, Mosconi A, Salvadori B, Rotella CM, Messeri G. (2006). Cystatin C reference values and aging. Clin Biochem 39:658–661.
   PubMed Web of Science ®Google Scholar
• Parkinson A, Mudra DR, Johnson C, Dwyer A, Carroll KM. (2004). The effects of gender, age, ethnicity, and liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193–209.
   PubMed Web of Science ®Google Scholar
• Pizzuti R, Caffari B, Binkin N, Argento G. (2006). Prescription drugs and the elderly: results of the Argento study. Ig Sanita Publica 62:11–26.
   PubMedGoogle Scholar
• Platten H-P, Schweizer E, Dilger K, Mikus G, Klotz U. (1998). Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther 63:552–560.
   PubMed Web of Science ®Google Scholar
• Ramsay SE, Whincup PH, Shaper AG, Wannamethee SG. (2006). The relations of body composition and adiposity measures to ill health and physical disability in elderly men. Am J Epidemiol 164:459–469.
   PubMed Web of Science ®Google Scholar
• Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S, Smith T, Fojo T, Bates S. (1999). Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glyocprotein-mediated drug efflux by PSC 833. Blood 93:306–314.
   PubMed Web of Science ®Google Scholar
• Saltzman JR, Kowdley KV, Perrone G, Russell RM. (1995). Changes in small-intestine permeability with aging. J Am Geriatr Soc 43:160–164.
   PubMed Web of Science ®Google Scholar
• Schmucker DL. (1998). Aging and the liver: an update. J Gerontol A Biol Sci Med Sci 53:B315–B320.
   PubMed Web of Science ®Google Scholar
• Schmucker DL. (2001). Liver function and phase 1 drug metabolism in the elderly: a paradox. Drugs Aging 18:837–851.
   PubMed Web of Science ®Google Scholar
• Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, Kremers P. (1990). Effect of age and gender on in vitro properties of human liver microsomal mono-oxygenases. Clin Pharmacol Ther 48:365–374.
   PubMed Web of Science ®Google Scholar
• Schwartz JB. (2006). Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin Pharmacol Ther 79:440–448.
   PubMed Web of Science ®Google Scholar
• Schwartz JB. (2007). The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 82:87–96.
   PubMed Web of Science ®Google Scholar
• Scordo MG, Pengo V, Spina E, Dahl ML, Gusella M, Padrini R. (2002). Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clerance. Clin Pharmacol Ther 72:702–710.
   PubMed Web of Science ®Google Scholar
• Shi S, Klotz U. (2008). Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol 64:233–252.
   PubMed Web of Science ®Google Scholar
• Shi S, Mörike K, Klotz U. (2008). The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 64:183–199.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
   PubMed Web of Science ®Google Scholar
• Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M. (2006). A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther 79:103–113.
   PubMed Web of Science ®Google Scholar
• Simon T, Becquemont L, Hamon B, Nouyrigat E, Chodjania Y, Poirier JM, Funck-Brentano C, Jaillon P. (2001). Variability of cytochrome P4501A2 activity over time in young and elderly healthy volunteers. Br J Clin Pharmacol 52:601–604.
   PubMed Web of Science ®Google Scholar
• Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. (1997). Age- and cytochrome P450-linked drug metabolism in humans: an analysis of 256 subjects with equal histophathological conditions. Clin Pharmacol Ther 61:331–339.
   PubMed Web of Science ®Google Scholar
• Sproule BA, Hardy BG, Shulman KI. (2000). Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 16:165–177.
   PubMed Web of Science ®Google Scholar
• Tateishi T, Fujimura A, Shiga T, Ohashi K, Ebihara A. (1995). Influence of ageing on the oxidative and conjugative metabolism of propranolol. Int J Clin Pharmacol Res 15:95–101.
   PubMedGoogle Scholar
• Taylor EM. (2002). The impact of efflux transporters in the brain on the development of drugs for CNS disorders. Clin Pharmacokinet 41:81–92.
   PubMed Web of Science ®Google Scholar
• Toornvliet R, van Berckel BNM, Luurtsema G, Lubberink M, Geldorf AA, Bosch TM, Oerlemans R, Lammertsma AA, Franssen EJF. (2006). Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[11C] verapamil and position emission tomography. Clin Pharmacol Ther 79:540–548.
   PubMed Web of Science ®Google Scholar
• Triggs E, Charles B. (1999). Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly. Clin Pharmacokinet 37:331–341.
   PubMed Web of Science ®Google Scholar
• Turnheim K. (1998). Drug dosage in the elderly. Is it rational? Drugs Aging 13:357–379.
   PubMed Web of Science ®Google Scholar
• Turnheim K. (2005). Pharmacokinetic dosage guidelines for elderly subjects. Exp Opin Drug Metab Toxicol 1:33–48.
   PubMedGoogle Scholar
• United Nations. World Population Aging (2007). (June, 2007). Available at: http:/www.un.org/esa/population/publications/WPA2007/wpp2007.htm. Accessed on August 26, 2007.
   Google Scholar
• Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. (1975). Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin Pharmacol Ther 18:425–432.
   PubMed Web of Science ®Google Scholar
• Villesen HH, Banning A-M, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, Christrup LL. (2007). Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Therap Clin Risk Manag 3:961–976.
   PubMedGoogle Scholar
• Wasén E, Isoaho R, Mattila K, Vahlberg T, Kivelä SL, Irjala K. (2004). Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med 256:70–78.
   PubMed Web of Science ®Google Scholar
• Wauthier V, Verbeeck RK, Calderon PB. (2007). The effect of ageing on cytochrome P450 enzymes: consequences for drug biotransformation in the elderly. Curr Med Chem 14:745–757.
   PubMed Web of Science ®Google Scholar
• Winkler MA. (1997). Aging: a global issue. JAMA 278:1377.
   PubMed Web of Science ®Google Scholar
• Woodhouse KW, Mutch E, Williams FM, Rawlins MD, James OF. (1984). The effect of age on pathways of drug metabolism in human liver. Age Ageing 13:328–334.
   PubMed Web of Science ®Google Scholar
• Woodhouse KW, O’Mahony MS. (1997). Frailty and ageing. Age Ageing 26:245–246.
   PubMed Web of Science ®Google Scholar
• Zang Y, Benet LZ. (2001). The gut as a barrier to drug absorption. Combined role of cytochrome P450 and P-glycoprotein. Clin Pharmacokinet 40:159–168.
   PubMed Web of Science ®Google Scholar
• Zeeh J, Platt D. (2002). The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121–127.
   PubMed Web of Science ®Google Scholar